GenesyzeCase StudiesApplication Development

Application Development

This case study shows how innovative technologies and clinical trial software can be applied to improve the speed, accessibility and quality of data, gathered and processed within clinical trials. Scroll down to discover more…

Previous Study Next Study
clinical trial software | Genesyze

Client Overview

Pharmaceutical (Major).

data capture | Genesyze

Research Question (Client problem)

How can we improve the speed, accessibility and quality of data, gathered and processed within clinical trials?

Clinical Trial software | Genesyze

Solution (Our Service)

Application development and deployment of a web-based technical solution: PACE.
Externally hosted implementation of the InForm application for Investigator and Monitor access, supported by Phase Forward.
An internal environment for interfaces and eCRF design.
Electronic data capture, cleansing and validation.

Clinical trial data insight | Genesyze

Benefits (Results)

PACE system accessible through the internet globally, interfacing with ICDS, OCEANS and Phase Forward systems.
Services clinical study teams and external investigator site representatives.
Delivers enhanced speed, accessibility and quality of data gathered and processed within Clinical trials.

clinical trial data capture | Genesyze

Technology, Programming and software

Oracle Client (Solaris) 9i.
Oracle Client 32-bit (Windows) 10g.
Oracle Client 32-bit (Windows) 9i.

clinical trial software | Genesyze

Insights

Technology enabled process improvements can improve workflow, accuracy of results and stakeholder connectivity in clinical research.

REACH OUT TODAY

Arrange a call back...

Please leave this field empty.
curve
curve

Latest News

Colette Hamilton, CEO and Principal Economist, will be providing economic support to the Integrated European Network on Chronic Graft Versus Host Disease (cGvHD), a major cause of non-relapse morbidity and mortality following allogeneic haematopoietic stem cell transplantation.

Colette Hamilton, CEO and Principal Economist, will be providing economic support to the Integrated European Network on Chronic Graft Versus Host Disease (cGvHD), a major cause of non-relapse morbidity and mortality following allogeneic haematopoietic stem cell transplantation.

Read more about the Integrated EU Network
Talk of Manchester Business Awards 2019. CEO, Colette Hamilton presents Best Digital Agency and Best Business Awards at the Talk of Manchester Business Awards on Thursday 6th December to a huge turn out.  #theTOMs supporting Kidscan charity

Talk of Manchester Business Awards 2019. CEO, Colette Hamilton presents Best Digital Agency and Best Business Awards at the Talk of Manchester Business Awards on Thursday 6th December to a huge turn out. #theTOMs supporting Kidscan charity

Read
Colette Hamilton, CEO, speaker at sponsored event, Pharma Pricing & Market Access EU 2018. Talk title; Redefining HEOR practice to meet the needs of a 21st century healthcare system:the economist’s perspective.

Colette Hamilton, CEO, speaker at sponsored event, Pharma Pricing & Market Access EU 2018. Talk title; Redefining HEOR practice to meet the needs of a 21st century healthcare system:the economist’s perspective.

Read
CEO Colette Hamilton attends the UK’s first LinkedInLocal networking event in the North, at the UKFast headquarters. Exciting collaborations in Manchester, the heart of the UK’s Northern Tech Powerhouse

CEO Colette Hamilton attends the UK’s first LinkedInLocal networking event in the North, at the UKFast headquarters. Exciting collaborations in Manchester, the heart of the UK’s Northern Tech Powerhouse

Read

This website uses cookies to give you the best experience. If you continue to use this site, we’ll assume that you’re happy to receive all cookies. View our Cookie Policy here.